Blue Earth Diagnostics IPO

blueearthdiagnostics.com

Blue Earth Diagnostics is a molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need.

Founded2014
Total Funding to Date$21.3MM
Register for Details

For more details on financing and valuation for Blue Earth Diagnostics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Blue Earth Diagnostics Ticker Symbol

Blue Earth Diagnostics does not have a ticker symbol because this company got acquired.

Blue Earth Diagnostics Stock Price

The stock price for Blue Earth Diagnostics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Other companies like Blue Earth Diagnostics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM